Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction
Corrado Betterle,
Chiara Dal Pra,
Franco Mantero and
Renato Zanchetta
Chair of Clinical Immunology and Allergy (C.B., C.D.P., R.Z.), Chair and Division of Endocrinology (F.M.), Department of Medical and Surgical Sciences, University of Padova, I-35128, Padova, Italy
Correspondence: Address all correspondence and requests for reprints to: Professor Corrado Betterle, M.D., Chair of Clinical Immunology and Allergy, Department of Medical and Surgical Sciences, University of Padova, Via Ospedale 105, 35128 Padova, Italy. E-mail: corrado.betterle{at}unipd.it
Recent progress in the understanding of autoimmune adrenal disease,including a detailed analysis of a group of patients with Addisonsdisease (AD), has been reviewed. Criteria for defining an autoimmunedisease and the main features of autoimmune AD (history, prevalence,etiology, histopathology, clinical and laboratory findings,cell-mediated andhumoral immunity, autoantigens and their autoepitopes,genetics, animal models, associated autoimmune diseases, pathogenesis,natural history, therapy) have been described. Furthermore,the autoimmune polyglandular syndromes (APS) associated withAD (revised classification, animal models, genetics, naturalhistory) have been discussed.
Of Italian patients with primary AD (n = 317), 83% had autoimmuneAD. At the onset, all patients with autoimmune AD (100%) haddetectable adrenal cortex and/or steroid 21-hydroxylase autoantibodies.In the course of natural history of autoimmune AD, the presenceof adrenal cortex and/or steroid 21-hydroxylase autoantibodiesidentified patients at risk to develop AD. Different risks ofprogression to clinical AD were found in children and adults,and three stages of subclinical hypoadrenalism have been defined.Normal or atrophic adrenal glands have been demonstrated byimaging in patients with clinical or subclinical AD.
Autoimmune AD presented in four forms: as APS type 1 (13% ofthe patients), APS type 2 (41%), APS type 4 (5%), and isolatedAD (41%). There were differences in genetics, age at onset,prevalence of adrenal cortex/21-hydroxylase autoantibodies,and associated autoimmune diseases in these groups. "Incomplete"forms of APS have been identified demonstrating that APS aremore prevalent than previously reported.
A varied prevalence of hypergonadotropic hypogonadism in patientswith AD and value of steroid-producing cells autoantibodiesreactive with steroid 17-hydroxylase or P450 side-chain cleavageenzyme as markers of this disease has been discussed. In addition,the prevalence, characteristic autoantigens, and autoantibodiesof minor autoimmune diseases associated with AD have been described.
Imaging of adrenal glands, genetic tests, and biochemical analysishave been shown to contribute to early and correct diagnosisof primary non-autoimmune AD in the cases of hypoadrenalismwith undetectable adrenal autoantibodies. An original flow chartfor the diagnosis of AD has been proposed.
This article has been cited by other articles:
A. Brozzetti, S. Marzotti, C. Tortoioli, V. Bini, R. Giordano, F. Dotta, C. Betterle, A. De Bellis, G. Arnaldi, V. Toscano, et al. Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies
Eur. J. Endocrinol.,
February 1, 2010;
162(2):
361 - 369.
[Abstract][Full Text][PDF]
R P Dias, L F Chan, L A Metherell, S H S Pearce, and A J L Clark Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency
Eur. J. Endocrinol.,
February 1, 2010;
162(2):
357 - 359.
[Abstract][Full Text][PDF]
N. Tomar, H. Bora, R. Singh, N. Gupta, P. Kaur, S. S. Chauhan, Y. D. Sharma, and R. Goswami Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members
Eur. J. Endocrinol.,
February 1, 2010;
162(2):
407 - 421.
[Abstract][Full Text][PDF]
M. Scacchi, L. Danesi, A. Cattaneo, E. Valassi, F. Pecori Giraldi, P. Radaelli, A. Ambrogio, E. D'Angelo, N. Mirra, L. Zanaboni, et al. The pituitary-adrenal axis in adult thalassaemic patients
Eur. J. Endocrinol.,
January 1, 2010;
162(1):
43 - 48.
[Abstract][Full Text][PDF]
A. La Marca, S. Marzotti, A. Brozzetti, G. Stabile, A. C. Artenisio, V. Bini, R. Giordano, A. De Bellis, A. Volpe, A. Falorni, et al. Primary Ovarian Insufficiency due to Steroidogenic Cell Autoimmunity Is Associated with a Preserved Pool of Functioning Follicles
J. Clin. Endocrinol. Metab.,
October 1, 2009;
94(10):
3816 - 3823.
[Abstract][Full Text][PDF]
I. Wallace, S. Cunningham, and J. Lindsay The diagnosis and investigation of adrenal insufficiency in adults
Ann Clin Biochem,
September 1, 2009;
46(5):
351 - 367.
[Abstract][Full Text][PDF]
G. J Kahaly Polyglandular autoimmune syndromes
Eur. J. Endocrinol.,
July 1, 2009;
161(1):
11 - 20.
[Abstract][Full Text][PDF]
U. Elbelt, S. Hahner, and B. Allolio Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy
Eur. J. Endocrinol.,
June 1, 2009;
160(6):
919 - 924.
[Abstract][Full Text][PDF]
G. P. S. Shantha, A. A Kumar, V. Jeyachandran, D. Rajamanickam, E. Bhaskar, V. K Paniker, and G. Abraham Paraneoplastic (non-metastatic) adrenal insufficiency preceded the onset of primary lung cancer by 12 weeks
BMJ Case Reports,
May 25, 2009;
2009(may25_1):
bcr0820080690 - bcr0820080690.
[Abstract][Full Text]
W. Arlt The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency
J. Clin. Endocrinol. Metab.,
April 1, 2009;
94(4):
1059 - 1067.
[Abstract][Full Text][PDF]
M. Alimohammadi, N. Dubois, F. Skoldberg, A. Hallgren, I. Tardivel, H. Hedstrand, J. Haavik, E. S. Husebye, J. Gustafsson, F. Rorsman, et al. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen
PNAS,
March 17, 2009;
106(11):
4396 - 4401.
[Abstract][Full Text][PDF]
M. M Erichsen, K. Lovas, K. J Fougner, J. Svartberg, E. R Hauge, J. Bollerslev, J. P Berg, B. Mella, and E. S Husebye Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death
Eur. J. Endocrinol.,
February 1, 2009;
160(2):
233 - 237.
[Abstract][Full Text][PDF]
L. Manetti, A. B Parkes, I. Lupi, G. Di Cianni, F. Bogazzi, S. Albertini, L. L. Morselli, V. Raffaelli, D. Russo, G. Rossi, et al. Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study
Eur. J. Endocrinol.,
December 1, 2008;
159(6):
805 - 809.
[Abstract][Full Text][PDF]
I. Gavanescu, C. Benoist, and D. Mathis B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: A therapeutic approach for APECED patients
PNAS,
September 2, 2008;
105(35):
13009 - 13014.
[Abstract][Full Text][PDF]
M. Alimohammadi, P. Bjorklund, A. Hallgren, N. Pontynen, G. Szinnai, N. Shikama, M. P. Keller, O. Ekwall, S. A. Kinkel, E. S. Husebye, et al. Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen
N. Engl. J. Med.,
March 6, 2008;
358(10):
1018 - 1028.
[Abstract][Full Text][PDF]
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev.,
February 1, 2008;
29(1):
76 - 131.
[Abstract][Full Text][PDF]
C. E. M. De Block, I. H. De Leeuw, and L. F. Van Gaal Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review
J. Clin. Endocrinol. Metab.,
February 1, 2008;
93(2):
363 - 371.
[Abstract][Full Text][PDF]
K. Reimand, J. Perheentupa, M. Link, K. Krohn, P. Peterson, and R. Uibo Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I
Int. Immunol.,
January 1, 2008;
20(1):
39 - 44.
[Abstract][Full Text][PDF]
E. S. Pires, P. K. Meherji, R. R. Vaidya, F. R. Parikh, M. N. Ghosalkar, and V. V. Khole Specific and Sensitive Immunoassays Detect Multiple Anti-ovarian Antibodies in Women With Infertility
J. Histochem. Cytochem.,
December 1, 2007;
55(12):
1181 - 1190.
[Abstract][Full Text][PDF]
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases
Endocr. Rev.,
August 1, 2007;
28(5):
492 - 520.
[Abstract][Full Text][PDF]
L. Manetti, I. Lupi, L. L. Morselli, S. Albertini, M. Cosottini, L. Grasso, M. Genovesi, G. Pinna, S. Mariotti, F. Bogazzi, et al. Prevalence and Functional Significance of Antipituitary Antibodies in Patients with Autoimmune and Non-Autoimmune Thyroid Diseases
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2176 - 2181.
[Abstract][Full Text][PDF]
I. Gavanescu, B. Kessler, H. Ploegh, C. Benoist, and D. Mathis Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity
PNAS,
March 13, 2007;
104(11):
4583 - 4587.
[Abstract][Full Text][PDF]
P. Candeloro, C. B. Voltattorni, R. Perniola, M. Bertoldi, C. Betterle, M. Mannelli, R. Giordano, A. De Bellis, C. Tiberti, S. Laureti, et al. Mapping of Human Autoantibody Epitopes on Aromatic L-Amino Acid Decarboxylase
J. Clin. Endocrinol. Metab.,
March 1, 2007;
92(3):
1096 - 1105.
[Abstract][Full Text][PDF]
R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, and G. Johannsson Premature Mortality in Patients with Addison's Disease: A Population-Based Study
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
4849 - 4853.
[Abstract][Full Text][PDF]
R. Giordano, M. Balbo, A. Picu, L. Bonelli, R. Berardelli, A. Falorni, E. Ghigo, and E. Arvat Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism?
Eur. J. Endocrinol.,
September 1, 2006;
155(3):
421 - 428.
[Abstract][Full Text][PDF]
A. De Bellis, M. Salerno, M. Conte, C. Coronella, G. Tirelli, M. Battaglia, V. Esposito, G. Ruocco, G. Bellastella, A. Bizzarro, et al. Antipituitary Antibodies Recognizing Growth Hormone (GH)-Producing Cells in Children with Idiopathic GH Deficiency and in Children with Idiopathic Short Stature
J. Clin. Endocrinol. Metab.,
July 1, 2006;
91(7):
2484 - 2489.
[Abstract][Full Text][PDF]
G. Coco, C. Dal Pra, F. Presotto, M. P. Albergoni, C. Canova, B. Pedini, R. Zanchetta, S. Chen, J. Furmaniak, B. Rees Smith, et al. Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1637 - 1645.
[Abstract][Full Text][PDF]
H. A. Tran Incidental Adrenal Insufficiency
JAMA,
March 8, 2006;
295(10):
1124 - 1124.
[Full Text][PDF]
D Shepshelovich and Y Shoenfeld Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity
Lupus,
March 1, 2006;
15(3):
183 - 190.
[Abstract][PDF]
C. Betterle, F. Lazzarotto, A. C. Spadaccino, D. Basso, M. Plebani, B. Pedini, S. Chiarelli, and M. Albergoni Celiac disease in North Italian patients with autoimmune Addison's disease
Eur. J. Endocrinol.,
February 1, 2006;
154(2):
275 - 279.
[Abstract][Full Text][PDF]
R. N. Miguel, S. Chen, L. Nikfarjam, S. Kominami, B. Carpenter, C. Dal Pra, C. Betterle, R. Zanchetta, T. Nakamatsu, M. Powell, et al. Analysis of the interaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling
Eur. J. Endocrinol.,
December 1, 2005;
153(6):
949 - 961.
[Abstract][Full Text][PDF]
F. Presotto, F. Fornasini, C. Betterle, G. Federspil, and M. Rossato Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature
Eur. J. Endocrinol.,
October 1, 2005;
153(4):
507 - 514.
[Abstract][Full Text][PDF]
J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment
Endocr. Rev.,
October 1, 2005;
26(6):
775 - 799.
[Abstract][Full Text][PDF]
D. Goswami and G. S. Conway Premature ovarian failure
Hum. Reprod. Update,
July 1, 2005;
11(4):
391 - 410.
[Abstract][Full Text][PDF]
J. M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J. C. Nelson, P. A. Gottlieb, M. Rewers, et al. Autoantibody "Subspecificity" in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups
Diabetes Care,
April 1, 2005;
28(4):
850 - 855.
[Abstract][Full Text][PDF]
M. Rotondi, A. Falorni, A. De Bellis, S. Laureti, P. Ferruzzi, P. Romagnani, A. Buonamano, E. Lazzeri, C. Crescioli, M. Mannelli, et al. Elevated Serum Interferon-{gamma}-Inducible Chemokine-10/CXC Chemokine Ligand-10 in Autoimmune Primary Adrenal Insufficiency and in Vitro Expression in Human Adrenal Cells Primary Cultures after Stimulation with Proinflammatory Cytokines
J. Clin. Endocrinol. Metab.,
April 1, 2005;
90(4):
2357 - 2363.
[Abstract][Full Text][PDF]
L Nikfarjam, S Kominami, T Yamazaki, S Chen, R Hewer, C Dal Pra, T Nakamatsu, C Betterle, R Zanchetta, B Rees Smith, et al. Mechanism of inhibition of cytochrome P450 C21 enzyme activity by autoantibodies from patients with Addison's disease
Eur. J. Endocrinol.,
January 1, 2005;
152(1):
95 - 101.
[Abstract][Full Text][PDF]
G. B. Piccoli, E. Mezza, M. Burdese, M. Terzolo, G. Grassi, F. Bermond, G. Soragna, M. Gai, F. Dani, A. Jeantet, et al. Progression of renal failure without proteinuria in a patient with type 1 diabetes
Nephrol. Dial. Transplant.,
December 1, 2004;
19(12):
3197 - 3199.
[Full Text][PDF]
C. Barnard, R. Kanani, and J. N. Friedman Her tongue tipped us off...
Can. Med. Assoc. J.,
August 31, 2004;
171(5):
451 - 451.
[Full Text][PDF]
G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes
N. Engl. J. Med.,
May 13, 2004;
350(20):
2068 - 2079.
[Full Text][PDF]
A. Falorni, S. Laureti, A. De Bellis, R. Zanchetta, C. Tiberti, G. Arnaldi, V. Bini, P. Beck-Peccoz, A. Bizzarro, F. Dotta, et al. Italian Addison Network Study: Update of Diagnostic Criteria for the Etiological Classification of Primary Adrenal Insufficiency
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1598 - 1604.
[Abstract][Full Text][PDF]
R. Giordano, M. Pellegrino, S. Oleandri, M. Baldi, M. Balbo, S. Laureti, A. Falorni, E. Ghigo, and E. Arvat Adrenal Sensitivity to Adrenocorticotropin 1-24 Is Reduced in Patients with Autoimmune Polyglandular Syndrome
J. Clin. Endocrinol. Metab.,
February 1, 2004;
89(2):
675 - 680.
[Abstract][Full Text][PDF]
M. Dittmar and G. J. Kahaly Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
2983 - 2992.
[Abstract][Full Text][PDF]
R. Gianani and G. S. Eisenbarth Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1442 - 1444.
[Full Text][PDF]
R. Silverstein and D. C. Johnson Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis
J. Leukoc. Biol.,
April 1, 2003;
73(4):
417 - 427.
[Abstract][Full Text][PDF]